Compendium of Cancer Genome Aberrations

GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2): Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 27: Line 27:


==Related Terminology==
==Related Terminology==
<span style="color:#0070C0">(''Instructions: This table will have the related terminology from the WHO book <u>autocompleted</u>.)''</span>
 
{| class="wikitable"
{| class="wikitable"
|+
|+
|Acceptable
|Acceptable
|
|Hereditary paraganglioma-phaeochromocytoma syndromes 1 to 5 (PGL1, PGL2, PGL3, PGL4, PGL5); Carney triad (restricted to syndromic but non-hereditary disease)
|-
|-
|Not Recommended
|Not Recommended
|
|N/A
|}
|}
Not Recommended:  Carney-Stratakis dyad/syndrome


==Definition/Description of Disease==
==Definition/Description of Disease==
Retrieved from "https://test.ccga.io/index.php/GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)"